17
Views
0
CrossRef citations to date
0
Altmetric
Miscellaneous

Salmeterol/fluticasone combination in COPD: is together better?

&
Pages 121-124 | Published online: 09 Jan 2014
 

Abstract

Chronic obstructive pulmonary disease represents one of the chronic conditions for which many therapies have become available during the last few decades. They are aimed at reducing symptoms such as dyspnea, cough and sputum and many of them are given on inhalatory route. Among them, bronchodilators, such as; salmeterol or formoterol and inhaled steroids, such as budesonide or fluticasone have each proven their effectiveness in improving many clinical outcomes such as dyspnea, exacerbations number, lung function decline or health status. Currently combinations of these two classes are available in an attempt to make the inhalatory therapy more effective. These studies analyse the effectiveness of salmeterol/fluticasone combination from a clinical point of view and for a short period of time.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.